Colin Ross is an Associate Professor in the Faculty of Pharmaceutical Sciences at the University of British Columbia and a Scientist at BC Children’s Hospital.
Dr. Ross’s expertise spans pharmacogenetics, genomics, drug development, drug safety, adverse drug reactions, predictive genetics, and genetic/clinical factors of drug response. Ross Lab researchers investigate the genetic basis of disease and severe adverse drug reactions using genomics-guided precision medicine approaches to help make drugs safer, improve disease diagnosis, and develop new, targeted therapeutics.
Dr. Ross’s research capitalizes upon national and international collaborations with clinicians, researchers and industry partners. He was instrumental in the establishment of the Canadian Pharmacogenomics Network for Drug Safety (CPNDS), a nation-wide collaborative network of researchers. He currently holds a leadership role on the network’s executive steering committee.
Dr. Ross has been the recipient of a number of awards, including a Scholar Award from the Michael Smith Foundation for Health Research, a New Investigator award from the Canadian Institutes of Health Research, a Champions of Genetics Award from the Canadian Gene Cure Foundation, the Boehringer-Ingelheim Award in Pharmacology Research from the Canadian Society of Pharmacology and Therapeutics, and the Excellence in Research Award from the American Society of Gene Therapy.
To get in touch with Dr. Ross or to enquire about a position at the Ross Lab, please see our contact page.